Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2014

Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507(7492):315-22.

Samad A, Attam R, Jessurun J, Pambuccian SE. Psammoma bodies and abundant stromal amyloid in an endoscopic ultrasound guided fine needle aspirate (EUS-FNA) of a pancreatic neuroendocrine tumor: a potential pitfall. Diagn Cytopathol. 2014;42(9):766-71.

Pekkonen P, Järviluoma A, Zinovkina N, Cvrljevic A, Prakash S, Westermarck J, et al. KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo. Cell Cycle. 2014;13(23):3670-84.

Branda JA, Rychert J, Burnham C-, Bythrow M, Garner OB, Ginocchio CC, et al. Multicenter validation of the VITEK MS v2.0 MALDI-TOF mass spectrometry system for the identification of fastidious gram-negative bacteria. Diagn Microbiol Infect Dis. 2014;78(2):129-31.

DeSimone RA, Ginter PS, Chen Y-. Granular cell tumor of the breast eliciting exuberant pseudoepitheliomatous hyperplasia. Int J Surg Pathol. 2014;22(2):156-7.

Magro CM, Hagen JW, Crowson AN, Liu YC, Mihm M, Drucker NM, et al. Hypopigmented interface T-cell dyscrasia: a form of cutaneous T-cell dyscrasia distinct from hypopigmented mycosis fungoides. J Dermatol. 2014;41(7):609-17.

Greenblatt MB, Torre M, Means J, Tanasijevic M, Pedulla LV, Bunnell CA, et al. Use of potassium concentrations as a quality-of-service metric for phlebotomists detects systematic preanalytical biases and facilitates their correction. Clin Chem. 2014;60(11):1453-5.

Hagen JW, Magro CM. Indolent CD8+ lymphoid proliferation of the face with eyelid involvement. Am J Dermatopathol. 2014;36(2):137-41.

Coates SJ, Mitchell K, Olorunnipa OB, DeSimone RA, Otterburn DM, Simmons RM. An unusual breast lesion: granular cell tumor of the breast with extensive chest wall invasion. J Surg Oncol. 2014;110(3):345-7.

Vitolo U, Chiappella A, Franceschetti S, Carella AM, Baldi I, Inghirami G, et al. Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial. Lancet Oncol. 2014;15(7):730-7.